全文获取类型
收费全文 | 9286篇 |
免费 | 945篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 165篇 |
儿科学 | 381篇 |
妇产科学 | 203篇 |
基础医学 | 1244篇 |
口腔科学 | 97篇 |
临床医学 | 938篇 |
内科学 | 1564篇 |
皮肤病学 | 355篇 |
神经病学 | 1004篇 |
特种医学 | 307篇 |
外科学 | 1258篇 |
综合类 | 241篇 |
一般理论 | 5篇 |
预防医学 | 1210篇 |
眼科学 | 134篇 |
药学 | 667篇 |
中国医学 | 4篇 |
肿瘤学 | 483篇 |
出版年
2021年 | 82篇 |
2020年 | 66篇 |
2019年 | 110篇 |
2018年 | 132篇 |
2017年 | 124篇 |
2016年 | 92篇 |
2015年 | 112篇 |
2014年 | 190篇 |
2013年 | 294篇 |
2012年 | 326篇 |
2011年 | 363篇 |
2010年 | 212篇 |
2009年 | 207篇 |
2008年 | 390篇 |
2007年 | 490篇 |
2006年 | 409篇 |
2005年 | 367篇 |
2004年 | 368篇 |
2003年 | 359篇 |
2002年 | 347篇 |
2001年 | 343篇 |
2000年 | 405篇 |
1999年 | 309篇 |
1998年 | 147篇 |
1997年 | 92篇 |
1996年 | 113篇 |
1995年 | 109篇 |
1994年 | 111篇 |
1993年 | 101篇 |
1992年 | 271篇 |
1991年 | 220篇 |
1990年 | 254篇 |
1989年 | 218篇 |
1988年 | 211篇 |
1987年 | 199篇 |
1986年 | 188篇 |
1985年 | 211篇 |
1984年 | 134篇 |
1983年 | 93篇 |
1982年 | 103篇 |
1981年 | 78篇 |
1980年 | 76篇 |
1979年 | 116篇 |
1978年 | 100篇 |
1977年 | 82篇 |
1976年 | 88篇 |
1975年 | 82篇 |
1974年 | 93篇 |
1973年 | 92篇 |
1972年 | 72篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Shane R. Stecklein Simona F. Shaitelman Gildy V. Babiera Isabelle Bedrosian Dalliah M. Black Matthew T. Ballo Isadora Arzu Eric A. Strom Valerie K. Reed Tomas Dvorak Benjamin D. Smith Wendy A. Woodward Karen E. Hoffman Pamela J. Schlembach Steve M. Kirsner Christopher L. Nelson Jinzhong Yang William Guerra Elizabeth S. Bloom 《Practical radiation oncology》2019,9(1):e4-e13
Purpose
This study aimed to prospectively characterize toxicity and cosmesis after accelerated partial breast irradiation (APBI) with 3-dimensional conformal radiation therapy (CRT) or single-entry, multilumen, intracavitary brachytherapy.Methods and materials
A total of 281 patients with pTis, pT1N0, or pT2N0 (≤3.0 cm) breast cancer treated with segmental mastectomy were prospectively enrolled from December 2008 through August 2014. APBI was delivered using 3-dimensional CRT (n = 29) or with SAVI (n = 176), Contura (n = 56), or MammoSite (n = 20) brachytherapy catheters. Patients were evaluated at protocol-specified intervals, at which time the radiation oncologist scored cosmetic outcome, toxicities, and recurrence status using a standardized template.Results
The median follow-up time is 41 months. Grade 1 seroma and fibrosis were more common with brachytherapy than with 3-dimensional CRT (50.4% vs 3.4% for seroma; P < .0001 and 66.3% vs 44.8% for fibrosis; P = .02), but grade 1 edema was more common with 3-dimensional CRT than with brachytherapy (17.2% vs 5.6%; P = .04). Grade 2 to 3 pain was more common with 3-dimensional CRT (17.2% vs 5.2%; P = .03). Actuarial 5-year rates of fair or poor radiation oncologist-reported cosmetic outcome were 9% for 3-dimensional CRT and 24% for brachytherapy (P = .13). Brachytherapy was significantly associated with inferior cosmesis on mixed model analysis (P = .003). Significant predictors of reduced risk of adverse cosmetic outcome after brachytherapy were D0.1cc (skin) ≤102%, minimum skin distance >5.1 mm, dose homogeneity index >0.54, and volume of nonconformance ≤0.89 cc. The 5-year ipsilateral breast recurrence was 4.3% for brachytherapy and 4.2% for 3-dimensional CRT APBI patients (P = .95).Conclusions
Brachytherapy APBI is associated with higher rates of grade 1 fibrosis and seroma than 3-dimensional CRT but lower rates of grade 1 edema and grade 2 to 3 pain than 3-dimensional CRT. Rates of radiation oncologist-reported fair or poor cosmetic outcomes are higher with brachytherapy. We identified dosimetric parameters that predict reduced risk of adverse cosmetic outcome after brachytherapy-based APBI. Ipsilateral breast recurrence was equivalent for brachytherapy and 3-dimensional CRT. 相似文献4.
Serena Luchenski Chantal Edge Niccola Hutchinson-Pascal Binta Sultan Georgia Black Stan Burridge Luke Johnson Natasha Palipane Diana Margot Rosenthal Cassandra Fairhead Emma King Dan Lewer Velvet Dibley Zana Khan Lucie Collinson Neha Pathak Alistair Story Andrew Hayward 《Lancet》2019
BackgroundInclusion Health aims to address and prevent the health harms of extreme inequity faced by excluded groups, including those affected by homelessness, drug addiction, imprisonment, and sex work. Engagement workshops with these groups have shown discordance between published research and what research they think is important. We aimed to involve these excluded groups and the wider service, policy, charity, and academic community who work with them to co-develop research and advocacy priorities.MethodsUsing a co-production approach, we held a 1-day event in London, UK, that involved inclusive, participatory, and consensus-building activities. We facilitated workshops on preventing exclusion, improving services for excluded groups, and escaping exclusion. We recorded participants’ views as observations, field notes, and ranked-lists of problems and suggested solutions. Professional artists captured frustrations and hopes for the future by drawing a visual representation. We conducted rapid thematic analysis of discussions on the day and triangulated these sources of information to develop research and advocacy priorities.FindingsApproximately 100 people attended, with at least 20 people with experience of exclusion. The other participants represented the National Health Service, various charity organisations, national, regional, and local government representatives, and several academic institutions. Emerging priorities included the following: tackling the upstream causes of exclusion (political determinants, poverty, and traumatic childhoods); addressing public and professional ignorance, indifference, and stigma by creating inclusion-focused public messages; making services more accessible and integrated through infrastructure (eg, national registries of services); putting excluded groups at the heart of health research, service development, and decision making, through the development of training for recruitment and co-design; and creating better routes out of exclusion.InterpretationDespite challenges in finding a common language, co-production effectively developed an Inclusion Health agenda aligned with the perceived needs of excluded groups and those who work with them. Funding agencies and the public health community should deliver this research agenda to improve the health and lives of people affected by exclusion.FundingUniversity College London Grand Challenges. 相似文献
5.
6.
Marla B. Ferschl Jennifer K. Lee Justin L. Lockman Stephanie Black Debnath Chatterjee Rita Agarwal Lawrence I. Schwartz John Fiadjoe Eugenie Heitmiller Bommy Hong Mershon Nina Deutsch John McCloskey Andrew Infosino 《Paediatric anaesthesia》2020,30(7):743-748
Promoting and retaining junior faculty are major challenges for many medical schools. High clinical workloads often limit time for scholarly projects and academic development, especially in anesthesiology. To address this, we created the East/West Visiting Scholars in Pediatric Anesthesia Program (ViSiPAP). The program's goal is to help “jumpstart” academic careers by providing opportunities for national exposure and recognition through invited lectures and collaborative opportunities. East/West ViSiPAP benefits the participating scholars, the home and hosting anesthesia departments, and pediatric anesthesia fellowship training programs. By fostering a sense of well‐being and inclusion in the pediatric anesthesia community, East/West ViSiPAP has the potential to increase job satisfaction, help faculty attain promotion, and reduce attrition. Faculty and trainees are exposed to new expertise and role models. Moreover, ViSiPAP provides opportunities for women and underrepresented in medicine faculty. This program can help develop today's junior faculty into tomorrow's leaders in pediatric anesthesia. We advocate for expanding the concept of ViSiPAP to other institutions in academic medicine. 相似文献
7.
Nicole A. Short Megan Lechner Kathy Bell Jenny Black Jennie Buchanan Jeffrey Ho Gordon Reed Amanda Corzine Ralph Riviello Sandra L. Martin Israel Liberzon Sheila Rauch Samuel A. McLean 《Journal of traumatic stress》2020,33(6):1111-1120
Anxiety sensitivity is a potential risk factor for posttraumatic stress symptoms (PTSS) and has been hypothesized to contribute to PTSS development. However, few prospective studies have evaluated whether anxiety sensitivity predicts PTSS. In a subsample of 48 women sexual assault survivors enrolled as part of a larger prospective observational study, elevated anxiety sensitivity measured via a brief assessment 1 week after experiencing a sexual assault was concurrently associated with PTSS at 1 week and prospectively predicted PTSS 6 weeks after the event, with small-to-medium effect sizes, η2p = .10, even after covarying for trauma history. Heightened anxiety sensitivity at 1-week postevent also interacted with time to predict anxiety and depression both before and after sexual assault, with medium-to-large effect sizes, ηp2 = .21– .24. This is consistent with research linking anxiety sensitivity to PTSS, but this was the first prospective study of which we are aware to demonstrate that anxiety sensitivity in the acute posttrauma period predicts PTSS among women who have recently experienced sexual assault. Future research should use the full Anxiety Sensitivity Index to replicate findings in a larger sample and explore whether targeting anxiety sensitivity could mitigate the development of PTSS in this vulnerable population. 相似文献
8.
Arindam Nandi Jere R. Behrman Maureen M. Black Sanjay Kinra Ramanan Laxminarayan 《Maternal & child nutrition》2020,16(1)
India's Integrated Child Development Services (ICDS) provides daily supplementary nutrition and other public health services to women and children. We estimated associations between exposure to early‐childhood ICDS nutrition and adult reproductive outcomes. During 1987–1990, a balanced protein–calorie supplement called “upma”—made from locally available corn–soya ingredients—was rolled out by subdistricts near Hyderabad and offered to pregnant women and children under age 6 years. In a controlled trial, 15 villages received the supplement and 14 did not. We used data from a 2010–2012 resurvey of adults born during the trial (n = 715 in intervention and n = 645 in control arms). We used propensity score matching methods to estimate the associations between birth in an intervention village and menarcheal age, age at first pregnancy, and fertility of adults. We found that women born in the intervention group during the trial, as compared with the control group, had menarche 0.45 (95% confidence interval [CI: 0.22, 0.68]; p < .001) years later and first pregnancy 0.53 (95% CI [0.04, 1.02]; p < .05) years later. Married women from the intervention group had menarche 0.36 (95% CI [0.09, 0.64]; p < .01) years later, first cohabitation with partner 0.8 (95% CI [0.27, 1.33]; p < .01) years later, and first pregnancy 0.53 (95% CI [0.04, 1.02]; p < .05) years later than married women in the control group. There was no significant difference between intervention and control group women regarding whether they had at least one childbirth or the total number of children born. The findings were similar when we employed inverse propensity score weighted regression models. 相似文献
9.
Joyce Black Michael Clark Carol Dealey Christopher T Brindle Paulo Alves Nick Santamaria Evan Call 《International wound journal》2015,12(4):484-488
The formulation of recommendations on the use of wound dressings in pressure ulcer prevention was undertaken by a group of experts in pressure ulcer prevention and treatment from Australia, Portugal, UK and USA. After review of literature, they concluded that there is adequate evidence to recommend the use of five‐layer silicone bordered dressings (Mepilex Border Sacrum® and 3 layer Mepilex Heel® dressings by Mölnlycke Health Care, Gothenburg, Sweden) for pressure ulcer prevention in the sacrum, buttocks and heels in high‐risk patients, those in Emergency Department (ED), intensive care unit (ICU) and operating room (OR). Literature on which this recommendation is based includes one prospective randomised control trial, three cohort studies and two case series. Recommendations for dressing use in patients at high risk for pressure injury and shear injury were also provided. 相似文献
10.
Eruptive syringoma is a very rare variant of syringoma. It is a benign adnexal tumor of the intraepidermal portion of eccrine sweat ducts. Here we report a 32-year-old female presented with classical asymptomatic eruptive syringomas involving her face and extremities. 相似文献